AstraZeneca's efforts to turn Brilinta into a blockbuster franchise show the group to be nothing ...
September 01, 2014
Even without a sham control group, the Anthem-HF trial of Cyberonics vagus nerve stimulation (VNS) ...
Ordinarily, a Japanese regulatory ruling on a new drug’s price would merit little more than a ...
July 28, 2014
June 17, 2014
June 10, 2014
April 17, 2014
FDA medtech approval slowdown hits surgical devices hardest
ESC preview – Novartis seeks Paradigm change and patients take neurostimulation to heart
Roche’s pricey move reinvigorates biotech fever
Valeant’s latest fight is over special Allergan meeting
Medtech Half-Year Review 2014
Medtech Employment Stable Despite Harsh Environment
Big Pharma Becomes a Smaller Employer While Biotech Booms
Pharma & Biotech 2013 in Review
Medtech 2013 in Review
Terms & Conditions
Follow us on Twitter